CN100369611C - Method for preparing freeze dried acanthopanax injectio - Google Patents

Method for preparing freeze dried acanthopanax injectio Download PDF

Info

Publication number
CN100369611C
CN100369611C CNB200410043998XA CN200410043998A CN100369611C CN 100369611 C CN100369611 C CN 100369611C CN B200410043998X A CNB200410043998X A CN B200410043998XA CN 200410043998 A CN200410043998 A CN 200410043998A CN 100369611 C CN100369611 C CN 100369611C
Authority
CN
China
Prior art keywords
alcohol
water
preparation
hours
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CNB200410043998XA
Other languages
Chinese (zh)
Other versions
CN1634274A (en
Inventor
李伟军
邢印田
施海平
张清波
徐丽华
姜滨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEILONGJIANG JINJIU PHARMACEUTICAL CO., LTD.
Original Assignee
HEILONGJIANG WANDASHAN PHARMACEUTICAL FACTORY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEILONGJIANG WANDASHAN PHARMACEUTICAL FACTORY filed Critical HEILONGJIANG WANDASHAN PHARMACEUTICAL FACTORY
Priority to CNB200410043998XA priority Critical patent/CN100369611C/en
Publication of CN1634274A publication Critical patent/CN1634274A/en
Application granted granted Critical
Publication of CN100369611C publication Critical patent/CN100369611C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a preparation method of an acanthopanax freeze drying powder injection solution used for injection. The production method of the existing acanthopanax freeze drying injection solution used for injection has the defects of low purity and low content of effective components. The preparation process of the preparation method of the acanthopanax freeze drying powder injection solution used for injection comprises the following steps: a. roots, rootstocks or stems of the acanthopanax is extracted by water or by alcohol; b. precipitation is carried out for more than 24 hours, and the alcohol is recovered and refrigerated for 24 hours after being added with water; c. adsorption is carried out by macroporous adsorption resin, and than, the adsorption resin is eluted by the alcohol, alcohol eluting liquid is recovered and alcohol is recovered until no alcohol taste exists; d. refrigeration and filtration by watering, sterilization, sterile subpackage, freeze drying and package are carried out. The preparation method of the present invention has the advantages of simple process and easy operation; the main components of medicine prepared by the method is clear; the present invention is suitable for industrial production, and is beneficial to popularization and application.

Description

A kind of preparation method of injection Radix Et Caulis Acanthopanacis Senticosi lyophilized injectable powder
Technical field:
The present invention relates to a kind of production method of injection Radix Et Caulis Acanthopanacis Senticosi freeze-dried powder.
Background technology:
There is the drawback that purity is low, active constituent content is low in the production method of existing injection Radix Et Caulis Acanthopanacis Senticosi freeze-dried powder.ZL94107718.7 discloses a kind of " Radix Et Caulis Acanthopanacis Senticosi extract and production technology thereof and the injection and the lyophilized injectable powder that contain this extract ", this patent has adopted the macroporous adsorbent resin decolouring in preparation process, with ethyl acetate extraction, will extract back liquid and processes such as destaining solution mixes, because extraction process can reduce the recovery of effective ingredient, and it is single to reclaim composition, and ethyl acetate toxicity is big, belong to combustibles again, can cause great injury to human body, its appropriate experimental chamber research is not suitable for suitability for industrialized production; And, steaming excess after this patent in the end will extract mixes with destaining solution, because destaining solution belongs to saccharide, micromolecule class, its impurity is very many, this mixing meeting reduces the purity of medicine greatly, reduce the content of effective ingredient, so in actual applications, the medicine that obtains with this method has the bad drawback of curative effect.
Summary of the invention:
The object of the present invention is to provide simple, the workable and effective ingredient gained medicine of a kind of production process to keep the preparation method of injection Radix Et Caulis Acanthopanacis Senticosi lyophilized injectable powder completely, its preparation process comprises the steps: that a. proposes root, rhizome or the stem water of Radix Et Caulis Acanthopanacis Senticosi or alcohol extraction, makes to contain alcohol amount and reach 80~88%; B. precipitate more than 24 hours, reclaim ethanol, add water-cooled again and hid 24 hours; C. use absorption with macroporous adsorbent resin, use the ethanol elution adsorbent resin then, reclaim eluting ethanol liquid, reclaim ethanol to there not being the alcohol flavor, detailed process is as follows: filtrate is joined in the macroporous adsorptive resins, flow velocity with 1500~4000ml/s flows out, impurity on elder generation's water flush away adsorption resin column, the reuse mass concentration is 80~85% ethanol elution, used amount of alcohol is 3~6 times of weight resin, collect ethanol elution, reclaim ethanol to not having alcohol flavor, the clear paste of relative density 1.10~1.15 when then gains being concentrated into 80 ℃; D. add water-cooled and hide filtration, sterilization, aseptic subpackaged, lyophilizing, packing gets final product.The present invention's purpose with absorption with macroporous adsorbent resin in the preparation of product process is not decolouring, but in order to adsorb the effective ingredient of medicine; The present invention does not mix adsorbate in the preparation process of product with effluent, but the effluent that will contain high impurity gives up, and the purity of products obtained therefrom is improved; The present invention gives up this process of usefulness ethyl acetate extraction in the prior art, can make main component ligustrin, the isofraxidin of medicine be able to abundant reservation like this, and the active constituent content of products obtained therefrom is improved; Preparation method of the present invention has simple, the maneuverable advantage of technology, and with the drug main definite ingredients of this method preparation, suitability for industrialized production is beneficial to and applies.
The specific embodiment:
The specific embodiment one: the preparation process of present embodiment comprises the steps: that a. proposes root, rhizome or the stem water of Radix Et Caulis Acanthopanacis Senticosi or alcohol extraction, makes to contain alcohol amount and reach 80~88%; B. precipitate more than 24 hours, reclaim ethanol, add water-cooled again and hid 24 hours; C. use absorption with macroporous adsorbent resin, use the ethanol elution adsorbent resin then, reclaim eluting ethanol liquid, reclaim ethanol to there not being the alcohol flavor; D. add water-cooled and hide filtration, sterilization, aseptic subpackaged, lyophilizing, packing gets final product.
The specific embodiment two: the preparation process of present embodiment is as follows: get Caulis Et Caulis Acanthopanacis Senticosi powder (sheet or section) or root powder (sheet or section) 40000g-50000g, decoct with water three times, each 2 hours, amount of water is 8 times of amount to 10 times amounts, gradation filters, merging filtrate, filtrate decompression is concentrated into the clear paste that relative density is 1.10-1.15 (80 ℃ of survey), adding ethanol makes the alcohol amount of containing reach 75%-88%, left standstill 24 hours, filter, filtrate recycling ethanol also is concentrated into the extractum of relative density 1.20-1.25 (80 ℃ of surveys), adding 2-3 doubly hid 24 hours to the water-cooled of crude drug amount, filter, filtrate is joined in the macroporous adsorptive resins, used adsorbent resin model is the AB-8 type, flow velocity with 1500~4000ml/s flows out then, the impurity on the first water flush away adsorption resin column, and the reuse mass concentration is 80~85% ethanol elution, used amount of alcohol is 3~6 times of weight resin, collect ethanol elution, reclaim ethanol to not having alcohol flavor, the clear paste of relative density 1.10~1.15 when then gains being concentrated into 80 ℃, put cold, the purified water or the water for injection that add 4~5 times of amounts again, cold preservation 24 hours filters, filtrate adds water to full dose, regulate pH value to 7.0~7.8, filter sterilization, packing, lyophilization, pre-freeze temperature-30 ℃, sublimation temperature≤-8 ℃, vacuum 0.1mmg; 30 ℃~35 ℃ of later stage baking temperatures, total sublimation drying 30~40 hours freezes altogether and makes 1000 injection Radix Et Caulis Acanthopanacis Senticosi powder pins.
Above-mentioned whole technical process quality control adopts senior liquid phase instrument control, and the preparation finger printing, and production process is simple, and is workable, is applicable to suitability for industrialized production.Through check, in 1000 Radix Et Caulis Acanthopanacis Senticosi injectable powder of said process gained, every contains syringoside (C 17H 24O 9) at 2.5mg~4.0mg, every contain Radix Et Caulis Acanthopanacis Senticosi total glucosides in syringoside at 60~80mg, every contains isofraxidin (C 11H 10O 3) 0.05mg~2.0mg, every contains dry matter weight is 200mg~600mg.
The specific embodiment three: present embodiment is got Radix Et Caulis Acanthopanacis Senticosi rhizome powder (or section or cutting) 40000g~50000g, add 75%~88% alcohol reflux 3 times, each 2~3 hours, adding amount of alcohol is 8~10 times, and gradation filters, and leaves standstill 24 hours, filter, filtrate recycling ethanol also is concentrated into the extractum of relative density 1.20~1.25 (80 ℃ of surveys), adds 2~3 times to the purified water or the water for injection of crude drug amount, cold preservation 24 hours, filter immersion and be added on macroporous adsorptive resins, the big pore adsorption resin model is AB-8, after adsorbing, and first water eluting, the reuse mass concentration is 80%~85% ethanol elution, collect ethanol elution, reclaim ethanol and be concentrated into the clear paste of relative density 1.10-1.15 (80 ℃ of surveys), put cold, the water for injection that adds 4~5 times of amounts, cold preservation 24 hours filters, and filtrate adds to the full amount of water for injection, regulate pH value to 7.0~7.8, filter sterilization, packing, lyophilization.Aforementioned pre-freeze temperature is-30 ℃, sublimation temperature≤-8 ℃, vacuum 0.1mmg.30 ℃~35 ℃ of later stage baking temperatures, total sublimation drying 30~40 hours is made 1000 injection Radix Et Caulis Acanthopanacis Senticosi powder pins altogether.
Above-mentioned whole technical process quality control adopts senior liquid phase instrument control, and the preparation finger printing, and production process is simple, and is workable, is applicable to suitability for industrialized production.Through check, in 1000 Radix Et Caulis Acanthopanacis Senticosi injectable powder of said process gained, every contains syringoside (C 17H 24O 9) at 2.5mg~4.0mg, every contain Radix Et Caulis Acanthopanacis Senticosi total glucosides in syringoside at 60~80mg, every contains isofraxidin (C 11H 10O 3) 0.05mg~2.0mg, every contains dry matter weight is 200mg~600mg.

Claims (3)

1. the preparation method of an injection Radix Et Caulis Acanthopanacis Senticosi lyophilized injectable powder is characterized in that its preparation process comprises the steps: that a. proposes root, rhizome or the stem water of Radix Et Caulis Acanthopanacis Senticosi or alcohol extraction, makes to contain alcohol amount and reach 80~88%; B. precipitate more than 24 hours, reclaim ethanol, add water-cooled again and hid 24 hours; C. use absorption with macroporous adsorbent resin, use the ethanol elution adsorbent resin then, reclaim eluting ethanol liquid, reclaim ethanol to there not being the alcohol flavor, detailed process is as follows: filtrate is joined in the macroporous adsorptive resins, flow velocity with 1500~4000ml/s flows out, impurity on elder generation's water flush away adsorption resin column, the reuse mass concentration is 80~85% ethanol elution, used amount of alcohol is 3~6 times of weight resin, collect ethanol elution, reclaim ethanol to not having alcohol flavor, the clear paste of relative density 1.10~1.15 when then gains being concentrated into 80 ℃; D. add water-cooled and hide filtration, sterilization, aseptic subpackaged, lyophilizing, packing gets final product.
2. the preparation method of a kind of injection Radix Et Caulis Acanthopanacis Senticosi lyophilized injectable powder according to claim 1, the process that it is characterized in that the d step is as follows: add the purified water or the water for injection of 4~5 times of amounts, cold preservation 24 hours filters, filtrate adds water to full dose, regulate pH value to 7.0~7.8, filter sterilization, packing, lyophilization, pre-freeze temperature-30 ℃, sublimation temperature≤-8 ℃, vacuum 0.1mmg; 30 ℃~35 ℃ of later stage baking temperatures, total sublimation drying 30~40 hours.
3. the preparation method of a kind of injection Radix Et Caulis Acanthopanacis Senticosi lyophilized injectable powder according to claim 1 and 2 is characterized in that described macroporous adsorbent resin model is an AB-8 type resin.
CNB200410043998XA 2004-10-29 2004-10-29 Method for preparing freeze dried acanthopanax injectio Active CN100369611C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB200410043998XA CN100369611C (en) 2004-10-29 2004-10-29 Method for preparing freeze dried acanthopanax injectio

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB200410043998XA CN100369611C (en) 2004-10-29 2004-10-29 Method for preparing freeze dried acanthopanax injectio

Publications (2)

Publication Number Publication Date
CN1634274A CN1634274A (en) 2005-07-06
CN100369611C true CN100369611C (en) 2008-02-20

Family

ID=34845946

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB200410043998XA Active CN100369611C (en) 2004-10-29 2004-10-29 Method for preparing freeze dried acanthopanax injectio

Country Status (1)

Country Link
CN (1) CN100369611C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101554370B (en) * 2008-04-08 2011-11-23 苑立超 Syringin for injection, preparation method and application thereof
CN102600221A (en) * 2012-04-20 2012-07-25 苏州大学 Preparation method of acanthopanax root extract

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1345592A (en) * 2000-09-29 2002-04-24 哈药集团中药二厂 Productive technology for producing Jiatong powder injection
CN1450060A (en) * 2002-04-10 2003-10-22 东北林业大学 Method for producing isoforaxidin, eleutheroside and eleutheran from Radix Acanthopanacis senticosi

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1345592A (en) * 2000-09-29 2002-04-24 哈药集团中药二厂 Productive technology for producing Jiatong powder injection
CN1450060A (en) * 2002-04-10 2003-10-22 东北林业大学 Method for producing isoforaxidin, eleutheroside and eleutheran from Radix Acanthopanacis senticosi

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
高效液相色谱-质谱联用技术分析刺五加抗疲劳化学成分. 王子灿,;乔善义;,马安德;等.第一军医大学学报,,第4卷第23期. 2003 *

Also Published As

Publication number Publication date
CN1634274A (en) 2005-07-06

Similar Documents

Publication Publication Date Title
CN101220062A (en) Method for preparing stevioside and rebaudiodside A simultaneously
CN103948659A (en) Preparation method of notoginseng leaf total saponins
CN101693047A (en) New method for extracting general stevioside of stevia rebaudiana under ultrahigh pressure
CN101538296B (en) Active ingredients of camptosorus sibiricus, and extraction method and use of same
CN114773218B (en) Preparation method of cortex lycii radicis-element
CN107759655B (en) Method for efficiently separating and purifying high-purity glycyrrhizic acid
CN107519227A (en) A kind of honeysuckle composition particle and preparation method thereof
CN101953883A (en) Chinese medicinal granules for treating calculosis and preparation method thereof
CN100369611C (en) Method for preparing freeze dried acanthopanax injectio
CN101234147A (en) Method of preparing total flavones of tropaeolum for injections
CN102225956A (en) Method for extracting and separating poliumoside from Gallicarpa kwangtungensis Chun
CN101757058B (en) General flavone extract of hollyhock flower, preparation thereof and application
CN105175426B (en) A kind of method of the extraction purification Bergenin from treebine stem
CN109453234B (en) Mulberry bark product and preparation method thereof
WO2023227138A1 (en) Method for extracting myricetin from lignum xanthocerais sorbifoliae
CN108403858B (en) Callicarpa nudiflora extract composition for treating hand-foot-and-mouth disease and application thereof
CN106924304A (en) The extracting method of Sweet tea active ingredient
CN102329350A (en) Method for extracting mulberroside A from white mulberry root-bark
CN101703554A (en) Preparation and use of semen cuscutae flavonoids
CN107619427A (en) A kind of method of the extraction purification rhizoma paridis saponin I from Paris polyphylla
CN111419892A (en) Extraction method of abrus herb total flavone
CN110585260A (en) Single-ingredient freeze-dried powder and preparation method thereof
CN106860502A (en) The preparation method of bitter melon seed flavones
CN113440547A (en) Method for separating and purifying Japanese thistle herb total glycosides by adopting macroporous resin series dynamic axial compression column
CN101450962B (en) Method for extracting oleanolic acid from Kandelia candel leaf

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: HEILONGJIANG WANDASHAN PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME: WANDASHAN PHARMACEUTICAL FACTORY, HEILONGJIANG

CP03 Change of name, title or address

Address after: Jixi City, Heilongjiang Province, Mishan City, the town of Pei

Patentee after: Heilongjiang Wandashan pharmaceutical Limited by Share Ltd

Address before: Jixi City, Heilongjiang Province, Mishan City, the town of Pei

Patentee before: Heilongjiang WanDaShan Pharmaceutical Factory

C53 Correction of patent for invention or patent application
C56 Change in the name or address of the patentee

Owner name: HEILONGJIANG JINJIU PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME: HEILONGJIANG WANDASHAN PHARMACEUTICAL CO., LTD.

CB03 Change of inventor or designer information

Inventor after: Zhang Qingbo

Inventor after: Zhang Meng

Inventor after: Jiang Bin

Inventor after: Bai Junchang

Inventor after: Hu Weiliang

Inventor after: Liao Hong

Inventor after: Wang Yanwei

Inventor after: Zhou Hongjin

Inventor after: Xing Yintian

Inventor after: Shi Haiping

Inventor after: Xu Lihua

Inventor after: Shi Shili

Inventor after: Gong Lijun

Inventor after: Jiang Ying

Inventor after: Li Weijun

Inventor after: Qiu Youhong

Inventor before: Zhang Qingbo

Inventor before: Zhang Meng

Inventor before: Jiang Bin

Inventor before: Xing Yintian

Inventor before: Shi Haiping

Inventor before: Xu Lihua

Inventor before: Shi Shili

Inventor before: Gong Lijun

Inventor before: Jiang Ying

Inventor before: Li Weijun

Inventor before: Qiu Youhong

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: ZHANG QINGBO XING YINTIAN SHI HAIPING XU LIHUA SHI SHILI GONG LIJUN JIANG YING LI WEIJUN QIU YOUHONG ZHANG MENG JIANG BIN TO: ZHANG QINGBO XING YINTIAN SHI HAIPING XU LIHUA SHI SHILI GONG LIJUN JIANG YING LI WEIJUN QIU YOUHONG ZHANG MENG JIANG BIN BAI JUNCHANG HU WEILIANG LIAO HONG WANG YANWEI ZHOU HONGJIN

CP01 Change in the name or title of a patent holder

Address after: 158300 Jixi City, Heilongjiang city in Mishan Province town of Pei

Patentee after: HEILONGJIANG JINJIU PHARMACEUTICAL CO., LTD.

Address before: 158300 Jixi City, Heilongjiang city in Mishan Province town of Pei

Patentee before: Heilongjiang Wandashan pharmaceutical Limited by Share Ltd